4//SEC Filing
Turner William D. 4
Accession 0001193125-25-308074
CIK 0001831828other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:05 PM ET
Size
8.4 KB
Accession
0001193125-25-308074
Insider Transaction Report
Form 4
Turner William D.
Chief Development Officer
Transactions
- Sale
Class A Common Stock
2025-12-03$40.00/sh−10,000$400,000→ 22,500 total - Exercise/Conversion
Class A Common Stock
2025-12-03$15.53/sh+10,000$155,300→ 32,500 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-03−10,000→ 265,000 totalExercise: $15.53Exp: 2034-01-04→ Class A Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.
- [F2]1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.
Documents
Issuer
Vera Therapeutics, Inc.
CIK 0001831828
Entity typeother
Related Parties
1- filerCIK 0001819688
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:05 PM ET
- Size
- 8.4 KB